Cargando…
Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
BIRC5 encodes the protein survivin, a member of the inhibitor of apoptosis family. Survivin is highly expressed in a variety of cancers but has very low expression in the corresponding normal tissues, and its expression is often associated with tumor metastasis and chemoresistance. We report that su...
Autores principales: | Zhao, Guannan, Wang, Qinghui, Gu, Qingqing, Qiang, Wenan, Wei, Jian-Jun, Dong, Peixin, Watari, Hidemichi, Li, Wei, Yue, Junming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706903/ https://www.ncbi.nlm.nih.gov/pubmed/29212257 http://dx.doi.org/10.18632/oncotarget.21863 |
Ejemplares similares
-
Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
por: Huo, Wenying, et al.
Publicado: (2017) -
miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
por: Wang, Baojin, et al.
Publicado: (2018) -
CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing
por: Chiang, Ting-Wei Will, et al.
Publicado: (2016) -
Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
por: Dong, Wendy, et al.
Publicado: (2021) -
SWISS: multiplexed orthogonal genome editing in plants with a Cas9 nickase and engineered CRISPR RNA scaffolds
por: Li, Chao, et al.
Publicado: (2020)